Shinhan Investment Corp. evaluated Digital Daesung on the 23rd as a beneficiary stock due to the increase in medical school admissions, stating that the popularity of Uidae-gwan will continue. They gave a 'Buy' rating and a target price of 9,600 KRW.


[Click eStock] "Digital Daesung, Medical School Building Popularity Expected... Beneficiary of Medical School Expansion" View original image

Joo Ji-eun, a researcher at Shinhan Investment Corp., said, "Digital Daesung is a leading dormitory academy and completed the acquisition of Hobeop Gangnam Daesung Dormitory Academy last month," adding, "In particular, the popularity of Uidae-gwan, which has strong brand power, will continue." She continued, "Considering the government budget plan, the increase in medical school admissions will continue until 2030," and noted, "The scale of the increase for the 2026 academic year is under discussion, but the fact that medical school admissions will increase remains unchanged."



Researcher Joo also said, "The dividend per share rose by 300 KRW from last year to 500 KRW, estimating this year's dividend yield at 7.3%," adding, "Additionally, they are pursuing tax-exempt dividends, which will be done by converting capital reserves into retained earnings."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing